TrialSignal
Clinical trial intelligence report
Induction of Salivary Neuromodulators by Chanting and Breathing Exercise
Source-linked diligence brief with registry provenance, taxonomy normalization and premium analytical context.
Generated
Jul 28, 2026
Report code
NCT02108769-Jul 28, 2026
NCT ID
NCT02108769
Status
COMPLETED
Phase
Completed
Sponsor
Medical University of South Carolina
Executive brief
Investment-Ready Snapshot
The study investigates the potential of ancient Tamil practices (chanting and breathing exercises) to stimulate the secretion of NGF in saliva, which has implications for neurodegenerative diseases such as Alzheimer's disease (AD). Given the increasing prevalence of AD and the limitations of current pharmacological treatments, this non-invasive approach could represent a novel therapeutic strategy. The findings may open avenues for further research and development of NGF as a therapeutic target, potentially leading to new market opportunities in neurodegenerative disease management. The integration of complementary and alternative medicine into mainstream healthcare could enhance patient outcomes and reduce healthcare costs, positioning this research favorably in the evolving biopharma landscape.
Source & freshness
Provenance
https://clinicaltrials.gov/study/NCT02108769
Indication
Alzheimer Disease
Modality
behavioral intervention
Target
Nerve Growth Factor (NGF)
Intervention
Yogic Breathing, Attention Control
Source record
Protocol Description
Detailed source ingestion pending.
Source record
Outcome Measures
Detailed source ingestion pending.
Source record
Eligibility
Detailed source ingestion pending.
AI analysis
Known Results And Readout Context
Detailed source ingestion pending.
IP intelligence
Patent And IP Landscape
Detailed source ingestion pending.
Source record
Contacts
Detailed source ingestion pending.